APO Research
Talk to an analyst

APO RESEARCH · REPORT

Probiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Probiotics CDMO Service Market Outlook and Growth Opportunities 2026

5 June 2026208 pages

Choose your research edition.

Industry ResearchProbiotics CDMO Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics CDMO Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Probiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics CDMO Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics CDMO Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Probiotics CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Probiotics CDMO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Probiotics CDMO Service market include Lallemand Health Solutions, Biofarma Group, ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Huro Biotech, CKD BiO Corp, Biose Industrie, Rise Therapeutics and Chr. Hansen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Probiotics CDMO Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotics CDMO Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotics CDMO Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Probiotics CDMO Service market.

Probiotics CDMO Service Segment by Company

Lallemand Health Solutions

Biofarma Group

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Huro Biotech

CKD BiO Corp

Biose Industrie

Rise Therapeutics

Chr. Hansen

Lonza AG

Exden

JuneYao Group (BioGrowing)

Sacco System

Falorni srl

Inpac Probiotics

Glac Biotech Co., Ltd

Probiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Probiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Probiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Probiotics CDMO Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Probiotics CDMO Service key companies, revenue, market share, and recent developments.

3. To split the Probiotics CDMO Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Probiotics CDMO Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Probiotics CDMO Service significant trends, drivers, influence factors in global and regions.

6. To analyze Probiotics CDMO Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Probiotics CDMO Service industry.

Chapter 3: Detailed analysis of Probiotics CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Probiotics CDMO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Probiotics CDMO Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Probiotics CDMO Service Industry Trends Table 2. Probiotics CDMO Service Industry Drivers Table 3. Probiotics CDMO Service Industry Opportunities and Challenges Table 4. Probiotics CDMO Service Industry Restraints Table 5. Global Probiotics CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Probiotics CDMO Service Revenue Share by Company (2021-2026) Table 7. Global Probiotics CDMO Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Probiotics CDMO Service Key Company Manufacturing Base & Headquarters Table 9. Global Probiotics CDMO Service Company, Product Type & Application Table 10. Global Probiotics CDMO Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Probiotics CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Dosage Forms (Capsules And Tablets) Table 15. Significant Companies of Powders and Granules Table 16. Significant Companies of Liquid Preparations Table 17. Global Probiotics CDMO Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Probiotics CDMO Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Probiotics CDMO Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Probiotics CDMO Service Sales Value Share by Type (2021-2026) Table 21. Global Probiotics CDMO Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medicines and Health Products Table 23. Significant Companies of Food Table 24. Significant Companies of Pet Food Table 25. Significant Companies of Cosmetics Table 26. Global Probiotics CDMO Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Probiotics CDMO Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Probiotics CDMO Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Probiotics CDMO Service Sales Value Share by Application (2021-2026) Table 30. Global Probiotics CDMO Service Sales Value Share by Application (2027-2032) Table 31. Global Probiotics CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Probiotics CDMO Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Probiotics CDMO Service Sales Value Share by Region (2021-2026) Table 34. Global Probiotics CDMO Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Probiotics CDMO Service Sales Value Share by Region (2027-2032) Table 36. Global Probiotics CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Probiotics CDMO Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Probiotics CDMO Service Sales Value Market Share by Country (2021-2026) Table 39. Global Probiotics CDMO Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Probiotics CDMO Service Sales Value Market Share by Country (2027-2032) Table 41. Lallemand Health Solutions Company Information Table 42. Lallemand Health Solutions Business Overview Table 43. Lallemand Health Solutions Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Lallemand Health Solutions Probiotics CDMO Service Product Portfolio Table 45. Lallemand Health Solutions Recent Development Table 46. Biofarma Group Company Information Table 47. Biofarma Group Business Overview Table 48. Biofarma Group Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Biofarma Group Probiotics CDMO Service Product Portfolio Table 50. Biofarma Group Recent Development Table 51. ILDONG Bioscience Co., Ltd. Company Information Table 52. ILDONG Bioscience Co., Ltd. Business Overview Table 53. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio Table 55. ILDONG Bioscience Co., Ltd. Recent Development Table 56. Bioprox Healthcare Company Information Table 57. Bioprox Healthcare Business Overview Table 58. Bioprox Healthcare Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bioprox Healthcare Probiotics CDMO Service Product Portfolio Table 60. Bioprox Healthcare Recent Development Table 61. Huro Biotech Company Information Table 62. Huro Biotech Business Overview Table 63. Huro Biotech Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Huro Biotech Probiotics CDMO Service Product Portfolio Table 65. Huro Biotech Recent Development Table 66. CKD BiO Corp Company Information Table 67. CKD BiO Corp Business Overview Table 68. CKD BiO Corp Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CKD BiO Corp Probiotics CDMO Service Product Portfolio Table 70. CKD BiO Corp Recent Development Table 71. Biose Industrie Company Information Table 72. Biose Industrie Business Overview Table 73. Biose Industrie Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Biose Industrie Probiotics CDMO Service Product Portfolio Table 75. Biose Industrie Recent Development Table 76. Rise Therapeutics Company Information Table 77. Rise Therapeutics Business Overview Table 78. Rise Therapeutics Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Rise Therapeutics Probiotics CDMO Service Product Portfolio Table 80. Rise Therapeutics Recent Development Table 81. Chr. Hansen Company Information Table 82. Chr. Hansen Business Overview Table 83. Chr. Hansen Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Chr. Hansen Probiotics CDMO Service Product Portfolio Table 85. Chr. Hansen Recent Development Table 86. Lonza AG Company Information Table 87. Lonza AG Business Overview Table 88. Lonza AG Probiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lonza AG Probiotics CDMO Service Product Portfolio Table 90. Lonza AG Recent Development Table 91. Exden Company Information Table 92. Exden Business Overview Table 93. Exden Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Exden Probiotics CDMO Service Product Portfolio Table 95. Exden Recent Development Table 96. JuneYao Group (BioGrowing) Company Information Table 97. JuneYao Group (BioGrowing) Business Overview Table 98. JuneYao Group (BioGrowing) Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio Table 100. JuneYao Group (BioGrowing) Recent Development Table 101. Sacco System Company Information Table 102. Sacco System Business Overview Table 103. Sacco System Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Sacco System Probiotics CDMO Service Product Portfolio Table 105. Sacco System Recent Development Table 106. Falorni srl Company Information Table 107. Falorni srl Business Overview Table 108. Falorni srl Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Falorni srl Probiotics CDMO Service Product Portfolio Table 110. Falorni srl Recent Development Table 111. Inpac Probiotics Company Information Table 112. Inpac Probiotics Business Overview Table 113. Inpac Probiotics Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Inpac Probiotics Probiotics CDMO Service Product Portfolio Table 115. Inpac Probiotics Recent Development Table 116. Glac Biotech Co., Ltd Company Information Table 117. Glac Biotech Co., Ltd Business Overview Table 118. Glac Biotech Co., Ltd Probiotics CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio Table 120. Glac Biotech Co., Ltd Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Probiotics CDMO Service Product Image Figure 2. Global Probiotics CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Probiotics CDMO Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Dosage Forms (Capsules And Tablets) Image Figure 8. Powders and Granules Image Figure 9. Liquid Preparations Image Figure 10. Global Probiotics CDMO Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Probiotics CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Probiotics CDMO Service Sales Value Share by Type (2021-2032) Figure 13. Medicines and Health Products Image Figure 14. Food Image Figure 15. Pet Food Image Figure 16. Cosmetics Image Figure 17. Global Probiotics CDMO Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Probiotics CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Probiotics CDMO Service Sales Value Share by Application (2021-2032) Figure 20. Global Probiotics CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Probiotics CDMO Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Probiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Probiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Probiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Probiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Probiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Probiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Probiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Probiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Probiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Probiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Probiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • Lallemand Health Solutions
  • Biofarma Group
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Huro Biotech
  • CKD BiO Corp
  • Biose Industrie
  • Rise Therapeutics
  • Chr. Hansen
  • Lonza AG
  • Exden
  • JuneYao Group (BioGrowing)
  • Sacco System
  • Falorni srl
  • Inpac Probiotics
  • Glac Biotech Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Probiotics CDMO Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Probiotics CDMO Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Probiotics CDMO Service Market Dynamics
  1. 2.1 Probiotics CDMO Service Industry Trends
  2. 2.2 Probiotics CDMO Service Industry Drivers
  3. 2.3 Probiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Probiotics CDMO Service Industry Restraints
3 Probiotics CDMO Service Market by Company
  1. 3.1 Global Probiotics CDMO Service Company Revenue Ranking in 2025
  2. 3.2 Global Probiotics CDMO Service Revenue by Company (2021-2026)
  3. 3.3 Global Probiotics CDMO Service Company Ranking (2024-2026)
  4. 3.4 Global Probiotics CDMO Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Probiotics CDMO Service Company Product Type and Application
  6. 3.6 Global Probiotics CDMO Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Probiotics CDMO Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Probiotics CDMO Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Probiotics CDMO Service Market by Type
  1. 4.1 Probiotics CDMO Service Type Introduction
  2. 4.1.1 Oral Dosage Forms (Capsules And Tablets)
  3. 4.1.2 Powders and Granules
  4. 4.1.3 Liquid Preparations
  5. 4.2 Global Probiotics CDMO Service Sales Value by Type
  6. 4.2.1 Global Probiotics CDMO Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Probiotics CDMO Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Probiotics CDMO Service Sales Value Share by Type (2021-2032)
5 Probiotics CDMO Service Market by Application
  1. 5.1 Probiotics CDMO Service Application Introduction
  2. 5.1.1 Medicines and Health Products
  3. 5.1.2 Food
  4. 5.1.3 Pet Food
  5. 5.1.4 Cosmetics
  6. 5.2 Global Probiotics CDMO Service Sales Value by Application
  7. 5.2.1 Global Probiotics CDMO Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Probiotics CDMO Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Probiotics CDMO Service Sales Value Share by Application (2021-2032)
6 Probiotics CDMO Service Regional Value Analysis
  1. 6.1 Global Probiotics CDMO Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Probiotics CDMO Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Probiotics CDMO Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Probiotics CDMO Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Probiotics CDMO Service Sales Value (2021-2032)
  7. 6.3.2 North America Probiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Probiotics CDMO Service Sales Value (2021-2032)
  10. 6.4.2 Europe Probiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Probiotics CDMO Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Probiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Probiotics CDMO Service Sales Value (2021-2032)
  16. 6.6.2 South America Probiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Probiotics CDMO Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Probiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
7 Probiotics CDMO Service Country-level Value Analysis
  1. 7.1 Global Probiotics CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Probiotics CDMO Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Probiotics CDMO Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Probiotics CDMO Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Probiotics CDMO Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Probiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Probiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lallemand Health Solutions
  2. 8.1.1 Lallemand Health Solutions Company Information
  3. 8.1.2 Lallemand Health Solutions Business Overview
  4. 8.1.3 Lallemand Health Solutions Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lallemand Health Solutions Probiotics CDMO Service Product Portfolio
  6. 8.1.5 Lallemand Health Solutions Recent Developments
  7. 8.2 Biofarma Group
  8. 8.2.1 Biofarma Group Company Information
  9. 8.2.2 Biofarma Group Business Overview
  10. 8.2.3 Biofarma Group Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biofarma Group Probiotics CDMO Service Product Portfolio
  12. 8.2.5 Biofarma Group Recent Developments
  13. 8.3 ILDONG Bioscience Co., Ltd.
  14. 8.3.1 ILDONG Bioscience Co., Ltd. Company Information
  15. 8.3.2 ILDONG Bioscience Co., Ltd. Business Overview
  16. 8.3.3 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio
  18. 8.3.5 ILDONG Bioscience Co., Ltd. Recent Developments
  19. 8.4 Bioprox Healthcare
  20. 8.4.1 Bioprox Healthcare Company Information
  21. 8.4.2 Bioprox Healthcare Business Overview
  22. 8.4.3 Bioprox Healthcare Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bioprox Healthcare Probiotics CDMO Service Product Portfolio
  24. 8.4.5 Bioprox Healthcare Recent Developments
  25. 8.5 Huro Biotech
  26. 8.5.1 Huro Biotech Company Information
  27. 8.5.2 Huro Biotech Business Overview
  28. 8.5.3 Huro Biotech Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huro Biotech Probiotics CDMO Service Product Portfolio
  30. 8.5.5 Huro Biotech Recent Developments
  31. 8.6 CKD BiO Corp
  32. 8.6.1 CKD BiO Corp Company Information
  33. 8.6.2 CKD BiO Corp Business Overview
  34. 8.6.3 CKD BiO Corp Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CKD BiO Corp Probiotics CDMO Service Product Portfolio
  36. 8.6.5 CKD BiO Corp Recent Developments
  37. 8.7 Biose Industrie
  38. 8.7.1 Biose Industrie Company Information
  39. 8.7.2 Biose Industrie Business Overview
  40. 8.7.3 Biose Industrie Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biose Industrie Probiotics CDMO Service Product Portfolio
  42. 8.7.5 Biose Industrie Recent Developments
  43. 8.8 Rise Therapeutics
  44. 8.8.1 Rise Therapeutics Company Information
  45. 8.8.2 Rise Therapeutics Business Overview
  46. 8.8.3 Rise Therapeutics Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Rise Therapeutics Probiotics CDMO Service Product Portfolio
  48. 8.8.5 Rise Therapeutics Recent Developments
  49. 8.9 Chr. Hansen
  50. 8.9.1 Chr. Hansen Company Information
  51. 8.9.2 Chr. Hansen Business Overview
  52. 8.9.3 Chr. Hansen Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chr. Hansen Probiotics CDMO Service Product Portfolio
  54. 8.9.5 Chr. Hansen Recent Developments
  55. 8.10 Lonza AG
  56. 8.10.1 Lonza AG Company Information
  57. 8.10.2 Lonza AG Business Overview
  58. 8.10.3 Lonza AG Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lonza AG Probiotics CDMO Service Product Portfolio
  60. 8.10.5 Lonza AG Recent Developments
  61. 8.11 Exden
  62. 8.11.1 Exden Company Information
  63. 8.11.2 Exden Business Overview
  64. 8.11.3 Exden Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Exden Probiotics CDMO Service Product Portfolio
  66. 8.11.5 Exden Recent Developments
  67. 8.12 JuneYao Group (BioGrowing)
  68. 8.12.1 JuneYao Group (BioGrowing) Company Information
  69. 8.12.2 JuneYao Group (BioGrowing) Business Overview
  70. 8.12.3 JuneYao Group (BioGrowing) Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio
  72. 8.12.5 JuneYao Group (BioGrowing) Recent Developments
  73. 8.13 Sacco System
  74. 8.13.1 Sacco System Company Information
  75. 8.13.2 Sacco System Business Overview
  76. 8.13.3 Sacco System Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sacco System Probiotics CDMO Service Product Portfolio
  78. 8.13.5 Sacco System Recent Developments
  79. 8.14 Falorni srl
  80. 8.14.1 Falorni srl Company Information
  81. 8.14.2 Falorni srl Business Overview
  82. 8.14.3 Falorni srl Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Falorni srl Probiotics CDMO Service Product Portfolio
  84. 8.14.5 Falorni srl Recent Developments
  85. 8.15 Inpac Probiotics
  86. 8.15.1 Inpac Probiotics Company Information
  87. 8.15.2 Inpac Probiotics Business Overview
  88. 8.15.3 Inpac Probiotics Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Inpac Probiotics Probiotics CDMO Service Product Portfolio
  90. 8.15.5 Inpac Probiotics Recent Developments
  91. 8.16 Glac Biotech Co., Ltd
  92. 8.16.1 Glac Biotech Co., Ltd Company Information
  93. 8.16.2 Glac Biotech Co., Ltd Business Overview
  94. 8.16.3 Glac Biotech Co., Ltd Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio
  96. 8.16.5 Glac Biotech Co., Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst